Beverly Paperiello is a pharmaceutical / biotech executive with more than 25 years of experience in drug development spanning early development through life cycle management. She has held positions of increasing responsibility and managed teams overseeing a range of clinical research activities. She has played a key role in the development of and regulatory filings for investigational drugs across the globe including Humira, Celebrex, Cresemba and Xtandi. She has had responsibility for over a $1 billion budget of clinical programs and has successful managed regulatory inspections with many healthy authorities globally.
Beverly received her Bachelor of Science in Health Administration from Northern Illinois University. Beverly loves animals, playing tennis, traveling and spending time with her two adult children, husband, two Golden Retrievers and friends.